...
首页> 外文期刊>Archives of pathology & laboratory medicine >Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.
【24h】

Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.

机译:真核翻译起始因子4E结合蛋白1在B细胞淋巴瘤和反应性淋巴组织中的表达和磷酸化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

CONTEXT: Cap-mediated messenger RNA translation controlled by the eukaryotic initiation factor 4F (eIF-4F) complex plays a key role in human cancer. eIF-4F activity is controlled by a repressor binding protein (4E-BP1), which promotes translation when phosphorylated. OBJECTIVE: To examine the level of expression and phosphorylation of 4E-BP1 in various subtypes of B-cell lymphoma and reactive lymphoid tissues. DESIGN: Archival formalin-fixed, paraffin-embedded B-cell lymphoma samples and reactive lymphoid tissues were immunostained and examined for expression of 4E-BP1 and phosphorylated 4E-BP1. Expression of components of the eIF-4F complex and unphosphorylated and phosphorylated 4E-BP1 was confirmed using Western immunoblotting on lysates of frozen lymphoma samples and reactive tissues. RESULTS: Immunohistochemical analysis demonstrated weak to undetectable 4E-BP1 staining within benign, reactive germinal centers (N = 10). In contrast, 4E-BP1 was consistently expressed (moderate to strong staining) in 98% of various subtypes of mature B-cell lymphoma (N = 50). 4E-BP1 expression was also demonstrable in all 4 lymph nodes with in situ or partial involvement by follicular lymphoma and in all 12 cases of BCL2-negative lymphoma. The level of phosphorylation of 4E-BP1 in lymphomas, evaluated by immunohistochemistry, was heterogeneous. CONCLUSIONS: The immunohistochemical expression pattern of 4E-BP1 exhibits regional and cellular specificity in reactive lymphoid tissues and may offer a diagnostic tool for distinguishing reactive follicles from neoplastic B-cell proliferations.
机译:语境:由真核起始因子4F(eIF-4F)复合体控制的帽介导的信使RNA翻译在人类癌症中起关键作用。 eIF-4F活性受阻遏物结合蛋白(4E-BP1)的控制,该蛋白在磷酸化时会促进翻译。目的:研究4E-BP1在B细胞淋巴瘤和反应性淋巴组织的各种亚型中的表达和磷酸化水平。设计:对福尔马林固定档案,石蜡包埋的B细胞淋巴瘤样本和反应性淋巴组织进行免疫染色,并检查4E-BP1和磷酸化4E-BP1的表达。使用Western免疫印迹法对冷冻的淋巴瘤样品和反应性组织的裂解物进行确认,证实了eIF-4F复合物以及未磷酸化和磷酸化的4E-BP1的成分表达。结果:免疫组织化学分析显示在良性,反应性生发中心(N = 10)中,弱至无法检测到的4E-BP1染色。相反,在成熟B细胞淋巴瘤的各种亚型中,有98%始终表达4E-BP1(中等至强染色)(N = 50)。在滤泡性淋巴瘤原位或部分受累的所有4个淋巴结中以及在所有12例BCL2阴性淋巴瘤中也证实了4E-BP1表达。通过免疫组织化学评估,淋巴瘤中4E-BP1的磷酸化水平是异质的。结论:4E-BP1的免疫组织化学表达模式在反应性淋巴组织中表现出区域和细胞特异性,可能为区分反应性滤泡和肿瘤性B细胞增生提供诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号